Synthesis and preliminary biological evaluation of the 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markers

Bioreductive therapies: an overview of drugs and their mechanisms of action

Andrew M. Rauth, T Melo, V Misra · International Journal of Radiation Oncology*Biology*Physics · 1998 · 104 citations

Medicine, Medicinal Chemistry, Pharmacology +7

In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.

James R. Ballinger, Judy Wan Min Kee, Andrew M. Rauth · PubMed · 1996 · 91 citations

Medicine, Oncology, Pharmacology +15

BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors.

T Melo, Jill Duncan, J R Ballinger et al. · PubMed · 2000 · 74 citations

Medicine, Oncology, Pharmacology +15

Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker

Taiwei Chu, Rujun Li, Shaowen Hu et al. · Nuclear Medicine and Biology · 2004 · 48 citations

Medicine, Nuclear Medicine, Oncology +11

Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia

Taiwei Chu, Shaowen Hu, Bing Wei et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 40 citations

Medicine, Nuclear Medicine, Oncology +14